Published in Gene Therapy Weekly, October 18th, 1999
G. Rabinovich and colleagues from the University of London Queen Mary and Westfield College, England, assessed the therapeutic effects and mechanisms of action of delivery of GAL-1 in a collagen-induced arthritis model. Their results were published in the Journal of Experimental Medicine ("Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis Via T-Cell Apoptosis," Journal of Experimental Medicine, 1999;190(3):385-397).
"Galectin-1, a member of a family of conserved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.